These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9329956)

  • 21. Modifier genes play a significant role in the phenotypic expression of PKD1.
    Fain PR; McFann KK; Taylor MR; Tison M; Johnson AM; Reed B; Schrier RW
    Kidney Int; 2005 Apr; 67(4):1256-67. PubMed ID: 15780078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diet and disease alter phosphoinositide composition and metabolism in murine polycystic kidneys.
    Aukema HM; Yamaguchi T; Tomobe K; Philbrick DJ; Chapkin RS; Takahashi H; Holub BJ
    J Nutr; 1995 May; 125(5):1183-91. PubMed ID: 7738678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender specificity in the genetic determinants of peak bone mass.
    Orwoll ES; Belknap JK; Klein RF
    J Bone Miner Res; 2001 Nov; 16(11):1962-71. PubMed ID: 11697792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo proton magnetic resonance imaging and localized spectroscopic analysis of polycystic kidney disease in DBA/2FG-pyc mice.
    Towner RA; Yamaguchi T; Philbrick DJ; Holub BJ; Janzen EG; Takahashi H
    Magn Reson Imaging; 1991; 9(3):429-34. PubMed ID: 1881263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice.
    Beamer WG; Shultz KL; Donahue LR; Churchill GA; Sen S; Wergedal JR; Baylink DJ; Rosen CJ
    J Bone Miner Res; 2001 Jul; 16(7):1195-206. PubMed ID: 11450694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease.
    Li KJ; Shiau AL; Chiou YY; Yo YT; Wu CL
    Kidney Int; 2005 May; 67(5):1710-22. PubMed ID: 15840017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal lipid and fatty acid compositions of kidneys from mice with polycystic kidney disease.
    Aukema HM; Yamaguchi T; Takahashi H; Celi B; Holub BJ
    Lipids; 1992 Jun; 27(6):429-35. PubMed ID: 1385849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteopontin deletion attenuates cyst growth but exacerbates fibrosis in mice with cystic kidney disease.
    Jansson KP; Kuluva J; Zhang S; Swanson T; Zhang Y; Zimmerman KA; Fields TA; Wallace DP; Rowe PS; Stubbs JR
    Physiol Rep; 2024 Sep; 12(17):e70038. PubMed ID: 39238069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic variations of orpk mutation and chromosomal localization of modifiers influencing kidney phenotype.
    Sommardahl C; Cottrell M; Wilkinson JE; Woychik RP; Johnson DK
    Physiol Genomics; 2001 Dec; 7(2):127-34. PubMed ID: 11773599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender-specific genetic determinants of blood pressure and organ weight: pharmacogenetic approach.
    Ueno T; Tremblay J; Kunes J; Zicha J; Dobesová Z; Pausova Z; Deng AY; Sun Y; Jacob HJ; Hamet P
    Physiol Res; 2003; 52(6):689-700. PubMed ID: 14640890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular pathophysiology of cystic kidney disease: insight into future therapies.
    Avner ED; Woychik RP; Dell KM; Sweeney WE
    Int J Dev Biol; 1999; 43(5):457-61. PubMed ID: 10535324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that soyasaponin Bb retards disease progression in a murine model of polycystic kidney disease.
    Philbrick DJ; Bureau DP; Collins FW; Holub BJ
    Kidney Int; 2003 Apr; 63(4):1230-9. PubMed ID: 12631339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinesin family member 12 is a candidate polycystic kidney disease modifier in the cpk mouse.
    Mrug M; Li R; Cui X; Schoeb TR; Churchill GA; Guay-Woodford LM
    J Am Soc Nephrol; 2005 Apr; 16(4):905-16. PubMed ID: 15728779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative genetics of age-related retinal degeneration: a second F1 intercross between the A/J and C57BL/6 strains.
    Danciger M; Yang H; Ralston R; Liu Y; Matthes MT; Peirce J; Lavail MM
    Mol Vis; 2007 Jan; 13():79-85. PubMed ID: 17277741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative trait loci for compensatory renal hypertrophy in the mouse.
    Zídek V; Musilová A; Vorlíèek J; Simáková M; Pravenec M
    Biochem Biophys Res Commun; 1998 Jul; 248(3):473-5. PubMed ID: 9703949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains.
    Berrettini WH; Ferraro TN; Alexander RC; Buchberg AM; Vogel WH
    Nat Genet; 1994 May; 7(1):54-8. PubMed ID: 8075641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of potassium citrate/citric acid intake in a mouse model of polycystic kidney disease.
    Tanner GA; Vijayalakshmi K; Tanner JA
    Nephron; 2000 Mar; 84(3):270-3. PubMed ID: 10720899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping quantitative trait loci that influence blood levels of alkaline phosphatase in MRL/MpJ and SJL/J mice.
    Srivastava AK; Masinde G; Yu H; Baylink DJ; Mohan S
    Bone; 2004 Nov; 35(5):1086-94. PubMed ID: 15542033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Klotho supplementation ameliorates blood pressure and renal function in DBA/2-pcy mice, a model of polycystic kidney disease.
    Takenaka T; Kobori H; Inoue T; Miyazaki T; Suzuki H; Nishiyama A; Ishii N; Hayashi M
    Am J Physiol Renal Physiol; 2020 Mar; 318(3):F557-F564. PubMed ID: 31928223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease.
    Omori S; Hida M; Fujita H; Takahashi H; Tanimura S; Kohno M; Awazu M
    J Am Soc Nephrol; 2006 Jun; 17(6):1604-14. PubMed ID: 16641154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.